CUPRIMINE DIN 00497894
Health Canada record
| Active ingredient(s) | PENICILLAMINE 125 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01CC01 PENICILLAMINE |
| Original market date | 31-Dec-1980 |
| Current status date | 18-Jun-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENICILLAMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00016055 | CUPRIMINE | BAUSCH HEALTH, CANADA INC. | Capsule | PENICILLAMINE 250 MG | Marketed |
| 00511641 | DEPEN TAB 250MG | CARTER-HORNER CORP. | Tablet | PENICILLAMINE 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7095 | 2005-06-17 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for PENICILLAMINE
3 valid EDQM Certificates of Suitability from 3 holders. 11 active FDA Drug Master Files.
Request a quote for CUPRIMINE